• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma (Editor)

    Thumbnail
    View/Open
    Baade506282-Accepted.pdf (141.9Kb)
    File version
    Accepted Manuscript (AM)
    Author(s)
    Claeson, M
    Baade, P
    Marchetti, M
    Brown, S
    Soyer, HP
    Smithers, BM
    Green, AC
    Whiteman, DC
    Khosrotehrani, K
    Griffith University Author(s)
    Baade, Peter D.
    Year published
    2021
    Metadata
    Show full item record
    Abstract
    Dear Editor, Despite overall favourable prognosis, thin (≤ 1·0 mm) cutaneous melanomas account for 23% of melanoma deaths in the high-risk general population of Queensland, Australia (2005–2009), because of the sheer volume of disease. The prospect of adjuvant systemic therapy has increased the focus on identifying patients with thin melanoma who are at high risk of death, such as through gene expression profiling (GEP), sentinel lymph node biopsy (SLNB) or prognostic models.Dear Editor, Despite overall favourable prognosis, thin (≤ 1·0 mm) cutaneous melanomas account for 23% of melanoma deaths in the high-risk general population of Queensland, Australia (2005–2009), because of the sheer volume of disease. The prospect of adjuvant systemic therapy has increased the focus on identifying patients with thin melanoma who are at high risk of death, such as through gene expression profiling (GEP), sentinel lymph node biopsy (SLNB) or prognostic models.
    View less >
    Journal Title
    British Journal of Dermatology
    DOI
    https://doi.org/10.1111/bjd.20480
    Copyright Statement
    © 2021 British Association of Dermatologists. This is the peer reviewed version of the following article: Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma (Editor), British Journal of Dermatology, 2021, which has been published in final form at https://doi.org/10.1111/bjd.20480. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
    Note
    This publication has been entered as an advanced online version in Griffith Research Online.
    Subject
    Clinical sciences
    Oncology and carcinogenesis
    Publication URI
    http://hdl.handle.net/10072/406599
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander